Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash Flows From Operating Activities:
Net loss	$ (5,539,543)	$ (6,677,587)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	23,688	134,754
Non-cash lease expense	81,258	73,579
Depreciation	12,865	13,683
Amortization of patents		228,107
Gain on forgiveness of PPP Loan and interest	(63,094)
Changes in operating assets and liabilities
Short term receivables	(1,449)	50,321
Prepaid expenses	265,957	347,107
Accounts payable	331,148	(170,413)
Unearned grant revenue	2,500,000
Other accrued expenses	502,581	244,887
Operating lease liability	(83,549)	(77,916)
Accrued interest expense	956,834	1,747,683
Net Cash Used In Operating Activities	(1,013,304)	(4,085,795)
Cash Flows From Financing Activities:
Proceeds from issuance of convertible notes payable	2,960,000	3,125,000
Proceeds from issuance of convertible notes payable - related parties	200,000	100,000
Repayment of short-term note payable	(248,177)	(105,985)
Proceeds from note payable		62,500
Deposit for purchase of Series D-1 Preferred Stock	150,000
Proceeds from exercise of warrants	962,223	418,676
Net Cash Provided By Financing Activities	4,024,046	3,600,191
Effect of exchange rates on cash, cash equivalents, and restricted cash	(1,031)	(7,871)
Net Increase (Decrease) In Cash, Cash Equivalents, and Restricted Cash	3,009,711	(493,475)
Cash, Cash Equivalents, and Restricted Cash, Beginning of Period	97,231	590,706
Cash, Cash Equivalents, and Restricted Cash, End of Period	3,106,942	97,231
Cash and cash equivalents	682,984	97,231
Restricted cash	2,423,958
Cash and cash Equivalents, restricted cash	3,106,942	97,231
Cash paid during the period for:
Interest
Income taxes
Non-cash investing and financing activities:
Purchase of insurance policies financed by short-term note payable	273,347	318,775
Conversion of non-amended 2017 Notes to Series D Preferred Stock	3,541,222
Conversion of amended 2017 Notes and 2020 Notes to Series D-1 Preferred Stock	27,031,858
Conversion of Series D-1 Preferred Stock to Common stock	$ 222